Pharmaceutical packaging is highly sophisticated industry as quality and safety issues are of utmost priority. Use of advanced technology and high grade plastic materials for pharmaceutical packaging is essence of the market success. In Bangladesh, 30 local pharmaceuticals plastic packaging material producers are capturing almost 70% of the local market while the rest (30%) that require extremely high-tech processing is import dependent. Nevertheless, some local plastic companies are setting up world-class dedicated plant for pharmaceutical plastic packaging, while some pharmaceutical companies such as Square and Acme are extending their facility into backward value segment of the plastic packaging industry. This study strives to determine the market size, major players of the industry-both from supply and demand sides-along with individual contribution in terms of value. It also outlines strategic imperatives for growth and competitiveness of the enterprises involved in the industry.
Introduction
Plastic based industry is very promising in Bangladesh which contributes almost 1% of the total GDP (Sazia & Kiptia, 2015) . The size of Domestic market is more than thousands billions USD. About 3000 companies are playing their role here where most of them are SMEs (Mansur, 2012) . In addition to others plastic is widely used in packaging purposes and it is the most usable material even than papers. (Nazmul, 2015) . It is so adaptable, rigid and tough what make it a very protective material to use in packaging industries. If the products needs to be confined and if the packaging for the products has to be convenient, then plastic is the essential element to use as it can be used as a variety of packaging purposes. However, considering compatibility, stability, easy transfer and other safety issues pharmaceutical companies are mostly dependent on plastic materials for packaging purposes which giving boost to the growth of plastic industries of Bangladesh
Working Definition of Pharmaceutical Packaging
For this study we considered Primary Packaging. Primary packaging means any single part of a container closure system. Typically containers, container liners, screw caps, stoppers, closure liners, stopper over seals, container inner seals, administration on large volume parenteral, overwraps, administration accessories and container labels. In this study a primary packaging component means a packaging component or its direct extension that comes in direct contact with the dosage form.
Broad Objectives
To identify the demand dynamics and supply dynamics and growth potential of pharmaceutical plastic packaging materials produced by the local enterprises.
Specific Objectives
a. To identify the market size of plastic packaging materials for pharmaceuticals in Bangladesh.
b. To identify the type of commonly use plastic packaging materials for pharmaceuticals in Bangladesh.
c. To identify the technical specialty for supplying plastic packaging materials for pharmaceuticals.
d. To identify the underlying causes of importing plastic packaging for pharmaceuticals in Bangladesh.
e. To identify the future prospects of plastic packaging for pharmaceuticals in Bangladesh.
Methodology
This is a qualitative exploratory research where both primary and secondary data has been used. For primary data an open-ended questionnaire was developed and respondents were interviewed face to face. For secondary data authors relied mostly on different journals, reference books, articles and various reputed websites. Since it is a small scale study, face to face interviews were conducted with the commercial/supply chain managers of top 10 pharmaceutical companies (by value) since they are responsible for the demand management of plastic packaging materials. It is worth mentioning that the top 10 pharmaceutical companies represent more than 69% of total pharmaceutical market of Bangladesh (IMS, 3Q, 16) . Besides leadership interviews were conducted with 05 leading industry experts, owners and association leader representing the plastic sector of Bangladesh. This was done to get more insight about the entire industry.
In order to gather further insights the supply chain manager of a multinational pharmaceutical company operating in Bangladesh beyond the list of top 10 was also interviewed. This was done primarily because of the perception that multinationals are very quality conscious and are required to maintain global standard.
Since the study will be qualitative and the answer will be open-ended; so, no special statistical analysis was done.
Literature Review

Demand Dynamics
Demand is the relationship between the quantities of a good or service consumers will purchase and the price charged for that good. The law of demand states that the quantity demanded for a good rises as the price falls, with all other things staying the same. The 'all other things staying the same' part is really important. There are other things that can affect demand besides price. They are prices of related goods or services, income, tastes or preferences and expectations. (Aaron Hill, 2003) . From the expert opinion, in case of plastic pharmaceutical packaging materials, quality becomes the key driving factor along with price since they are highly sensitive.
At a Glance Plastic Industry of Bangladesh
Plastic is an engineered material used to manufacture a wide variety of products to meet the domestic demand in Bangladesh as well as some products are exported. The plastic industry has emerged as an important industrial sector in the country during the last two decades. At present there are 3,000 plastic manufacturing units, 98% of which belong to the Small-Medium Enterprises (SMEs). Domestic market size is Tk 7,000 crore. Per capita consumption of plastics in Bangladesh is 5 kg per year. The plastic sector constitutes 1% of GDP and provides employment for half a million people. (Mansur, 2012) 
Purpose of Using Plastic Packaging Materials in Pharmaceuticals
Purpose of using plastic packaging materials in pharmaceuticals includephysical and chemical stability of the medicine (being an effective barrier to light, moisture, oxygen, bacteria, volatiles, etc. as appropriate), mechanical trauma-protection from damage, During transit, distribution and storage of the product, maintaining product integrity untilit's in-use phase is completed or the expiry date stated on the label has passed. (Simon Mills, 2010) . 
Development History of Plastic Industry of Bangladesh
Plastics Uses in Pharmaceutical Packaging
a. Polyethylene (PE): Provides good barrier against moisture, relatively poor one against oxygen and other gases. High density polyethylene is used with density ranging from 0.91-0.96 leading to four basic characteristics of container, (1) Stiffness, (2) Moisture-vapor transmission, (3)stress cracking and(4)clarity or translucency based on polymer density used.
b. Polypropylene (PP):
Polypropylene has features of polyethylene in addition it does not stress-crack in any condition. Hot aromatic or halogenated solvents soften the package. It has high melting point making it suitable for boilable packages and products needed to be sterilized. Brittleness at low temperature is its major disadvantages.
c. Polyvinyl Chloride (PVC):
Can be produced with crystal clear clarity, will provide good gaseous barrier and stiffness. Reduction in residual vinyl chloride monomers had further enhanced PVC quality. PVC is used as coating on glass bottles providing shatter resistant coating.
d. Polyvinylidene chloride (PVDC):
It is a remarkable barrier against water, oxygen and aromas. It has a superior chemical resistance to alkalies and acids, is insoluble in oil and organic solvents, has very low moisture regain and is impervious to mould, bacteria, and insects. But it is soluble in polar solvents.
e. Polystyrene: Rigid and crystal clear plastic. Not useful for liquid products. Polystyrene has high water and gaseous permeability also these are easily stretchable and breakable. To increase their strength and quality for permeability polystyrene is combined with rubber and acrylic compounds. Base on the composition these are classified as intermediate impact, high impact and super impact packages.
f. Nylon (polyamide):
Many dibasic acids and amines combine to provide numerous varieties of nylon. Nylon is extremely strong and is quite difficult to be destroyed by mechanical means. Nylon provides resistance to wide range of acids and alkali only disadvantage of it is being permeable to water vapor for some amount this can also be dealt with coating of PE over the container. Not used for long term storage of products.
g. Polycarbonate:
Has an ability to be sterilized repeatedly. It has immense rigidity and is a possible replacement for glass, vials and syringes. It has qualities like high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, and resistance to heat and flame. Polycarbonates have impact strength five times greater than any other common packaging plastics.
h. Acrylic multipolymers (Nitrile Polymers): These are polymers of acrylonitrile or methacrylonitrile monomers. These provide for packaging of those products which are not packed in usual packages as they provide for high gas barrier, good chemical resistance, and good strength.
i.
Polyethylene terepthalate (PET): Condensation polymer formed by reaction of terepthalic acid or dimethyl terepthalic acid with ethylene glycol. It has excellent strength and provides barrier for gas and aroma making it as a useful package for cosmetics, mouth washes and other products. (Pareeket al.2014 ).
Key Issues in Selecting Pharmaceutical Packaging
Plastic packaging systems for pharmaceutical products must be suitable for their intended use. That is, the packaging system should adequately protect the pharmaceutical product, should be compatible with the pharmaceutical product, and should be composed of materials that are safe for use. From a chemical perspective, plastic packaging systems used in pharmaceutical applications should be such that the ingredients of the pharmaceutical product are not adsorbed onto the surface of the packaging system, are not absorbed into the body of the packaging system, and do not migrate through the packaging system (compatibility). Further, the packaging system should not release substances that can accumulate in the pharmaceutical product in quantities sufficient to affect its stability (which addresses compatibility) or to present a risk of toxicity (Rock Ville, 2013) .
Recent Trend in Pharmaceutical Plastic Packaging
Pharmaceutical packaging is a lucrative market-predicted to reach a global value of $80 billion by 2020. In part that growth is due to aging populations in the developed world as well as better access to pharmaceuticals in the developing world. Yet industry challenges such as child-resistant packaging, CSR, counterfeits and prescription compliance are changing the way pharma manufacturers approach packaging. Here are the trends to watch out for. (Trevor Nicholas, 2016) 
Categories of Pharmaceutical Packaging
Primary packaging system is the material that first envelops the product and holds it i.e., those package components and subcomponents that actually come in contact with the product, or those that may have a direct effect on the product shelf life e.g., ampoules and vials, prefilled syringes, IV containers, etc.
Secondary packaging system is outside the primary packaging and used to group primary packages together e.g., cartons, boxes, shipping containers, injection trays, etc.
Tertiary packaging system is used for bulk handling and shipping e.g., barrel, container, edge protectors, etc. (Nityanand Zadbuke et al., 2013) 
Important Issues Affecting Pharmaceutical
Findings
Market Size & Market Players
From the in-depth interview of Commercial Heads of top 10 companies it is estimated that the approximate market size of Bangladeshi pharmaceutical plastic packaging materials is $ 25 million (BDT 200 Crore) which is currently growing with an average rate of 25%. By quantity (number of items) less than 20% of the entire market is import dependant but by value it is 30% since imported items are involved with high cost. Locally the market growth shows a consistent upward trend over the last 10 to 15 years. Besides, there is a huge demand for plastic packaging globally which if tapped, would be further boost the growth of the local industry.
Company-Wise Approximate Demand Contribution (%)
Top two pharmaceutical companies consume more than one-fourth of the total market demand, while top 11 accounts for more than 70%. The table below shows the demand distribution of plastic packaging for pharmaceuticals:
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The Major Local Suppliers and Their Categories
The study has identified 30 notable manufacturers. Based on their business relationship with top 10 pharmaceutical companies, these are categorized as large, medium and small. 
The Major Foreign Suppliers Include the Followings
As mentioned earlier, packaging products requiring top quality processing are sourced by import. The study has identified major foreign companies (along with their country of origin) doing business with Bangladesh. These are as follows. 
Commonly Used Plastic Materials for Pharmaceutical Packaging
There are many different forms of plastic packaging materials that are being used in pharmaceutical packaging. Among them PVDC film, PVC film and PET bottle together accounts for, in terms of value, 37%. The Table  below presents description of major plastic materials used in pharmaceuticals, along with their respective share and source of procurement. 
Technical Issues of Pharmaceutical Packaging Materials
As drug products come into direct contact with packaging systems and their plastic materials of construction. Such contact may result in interactions between the drug product and its packaging system. The packaging systems must protect and be compatible with drug products and not compromise their stability, efficacy or safety. In turn, the ingredients of a drug product should not be absorbed onto the surface or migrate into the body of the plastic packaging system.
However, top local manufacturers imports food grade virgin active ingredients for producing plastic packaging materials from Korea, Taiwan, Malaysia, Saudi Arabia, UAE, China etc which are little costly and the pharmaceutical manufacturer have some quality parameters to select that same. Apart from basic materials working environment & machine also play role in the quality of the products.
Top local manufacturers have world class high standard machine & environment for producing plastic packaging materials but some other plastic manufacturer are far behind that standard.
The pharmaceutical companies who are exporting medicine to semi-regulated & regulated markets are very careful about the sources of plastic materials since there are some strict guidelines for packaging materials from regulatory body. Therefore, they expect certain SOP (Standard Operating Procedure) & COA (Certificate of Analysis) from the plastic manufacturer. Therefore, these export oriented companies limited their purchase only from top class plastic manufacturer.
Import Issues
PVC/PVDC/HDP films, Flexible large volume parenteral container, Special Tube Type Container, Infusion Set, ijbm.ccsenet.org
International Journal of Business and Management Vol. 12, No. 3; 2017 Actuator, Applicator and Spray Pumps are the items that import on regular basis. Some local companies are manufacturing PVC/PVDC film but due quality, appearance, perception and price they are not getting good market access. Special Tube Type Container is used by very few pharmaceutical companies and quantity is not very high. Therefore, local manufacturer are not interested to produce that same but they have the capacity to do it. Flexible large volume parenteral container production involved with very sophisticated technology; hence, local companies are not manufacturing it. Some containers for sterile liquid preparation like ophthalmic sterile liquid container are being imported since desired sterilization facility is unavailable but these containers are easy to manufacture. However, import of pharmaceutical packaging items also involved with some challenges like long lead time, uncertainty, high duty, price increment in final goods etc.
At a glance item-wise underlying cause of import 
Growth Potential
The global pharmaceutical packaging market is expected to witness significant push due to incessantly rising demand of biologics. Advances in biotechnology often lead to the introduction of new therapies that must be injected; the pharmaceutical packaging market is expected to witness fastest growth from pre-fillable syringes and parenteral vials. Availability of raw materials and price volatility coupled with changing health regulations are the major deterrents which is curbing the growth of this market.
The fastest growth in the pharmaceutical packaging market is expected to come from pre-fillable syringes and parenteral vials, which will continue to expand as advances in biotechnology lead to the introduction of new therapies that must be injected. The increasing demand for biologics will strengthen demand for innovative product packaging solutions in the global pharmaceutical packaging market. All these factors, along with the growing pharmaceutical industry, will continue to drive demand for packaging. However, the packaging industry will have to overcome challenges, such as the availability and price volatility of raw materials and changing health regulations, in order to meet increasing demand from the growing pharmaceutical industry.
The growth of this industry is directly proportional with the growth of pharmaceutical industry. The market growth of this industry is expected to be very high since both local & global market of Bangladeshi pharmaceuticals is growing very fast. Some top plastic manufacturers are planning to export pharmaceutical packaging to Europe & America where market size is robust. Pharmatech Polymer is setting up dedicated plant for pharmaceutical plastic packaging, Pran Group is focusing on pharmaceutical plastic solution, Square and Acme are extending their facilities to produce plastic packaging materials. These all indicate that local companies are improving their capacity & quality in plastic packaging which is giving hope in import reduction, ultimately increase in local product demand.
World demand for pharmaceutical packaging products will increase 6.5 percent annually to over $100 billion in 2019. Because of advanced and diverse drug-producing industries, almost 60 percent of global demand will come from the developed economies of Canada, Japan, the US, and Western Europe. India and China will form the fastest growing markets due to rapidly expanding pharmaceutical manufacturing capabilities and the adoption of more stringent regulations aimed at improving the quality and integrity of domestically produced medicines. Russia, Turkey, Mexico, Iran, Argentina, and Brazil are among other developing markets that are expected to expand and diversify drug-producing industries and register above average gains in pharmaceutical packaging demand. The Africa/Mideast region will be the fastest growing market, followed by the Asia/Pacific region and Central and South America. Primary containers will remain the dominant segment, led by prefillable syringes and parenteral vials. (Markets & markets, 2016) . Due to low production cost Bangladesh may be an impressive hub for plastic packaging materials.
Conclusions & Strategic Imperatives
Considering the recent growth of the pharmaceutical industry in Bangladesh coupled with technological advancement involving plastic packaging, it may be concluded that the growth potential of plastic-based pharmaceutical packaging is quite high. If the local manufacturers concentrate on customer-centric innovations and maintain quality consistently, then they will be able not only to capture the entire local market, but also to enter into the global market. However, in order for them to reach that height, it is therefore recommended that initiatives are taken around the following:
Use of High Quality Basic Materials
Pharmaceutical plastic packaging materials needs to be produced from Food Grade Virgin materials but there are some manufacturers who are using general grade materials to minimize the cost. Local manufacturers are importing basic materials from different sources and producing the final goods here. Due to changes in sources of raw materials quality of final goods sometimes become changed. Therefore, quality of basic materials needs to be ensured.
Technological Up-Gradation
Still now our producers are not in shape enough to produce so many items due to technological limitation. Also, there are some companies who use semi-automated or manual machine where chance of contamination is very high. To avoid such limitations technological up gradation is utmost priority.
Ensuring Standard Working Environment
Although very few companies have good working environment and supplying packaging materials to multinational companies but many companies are not marinating pharmaceutical standard. Even there are some companies who have not any SOP for meeting the compliance.
Proper Documentation
In case of pharmaceutical plastic packaging item production documentation is basic requirement but our local manufacturers are putting very less attention on that. This issue needs to be addressed to meet regulatory guidelines.
Continues Innovation
In maximum cases our manufacturers usually collect samples from different sources including pharmaceutical companies and produce the copy products. They have limited or no R&D facilities. Due to this limitation aesthetic value of local products is behind the global standard and there is no variation in size & shape. Therefore, innovation in size, shape & appearance is important.
Entrepreneurship
Except one or two there is no dedicated pharmaceutical plastic packaging manufacturer in the country. Those who produce pharmaceutical plastic packaging materials also produce other plastic items. For pharmaceutical supply additional precaution & sensitivity are required which involved high cost whereas by using the same cost more output can be obtained in other items as quality issues do not get so priority. This motivates the entrepreneurs to make a check and balance between pharmaceutical packaging & other items which have a direct impact on quality standard. Therefore, if some dedicated plants are established then a class of manufacturers can be distinguished themselves from others and will easily get more market access considering quality parameters.
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